Safe Removal Of Radium From Indian Hospitals And Its Replacement With Safer Substitutes – Essay
Indian hospitals began using radium-226 for cancer brachytherapy in the early twentieth century, eventually holding about 20 grams across more than sixty-five institutions, but aging sources created serious leakage, contamination and occupational-exposure risks.
The Directorate of Radiation Protection at BARC provided free inspections, leak testing, source recovery and decontamination, including unusual recoveries from crematoriums and hospital waste, before a national program collected and disposed of defective radium.
A mailed track-etch detector study and media coverage helped secure funding for cesium-137 after-loading systems; AERB banned radium use in 1988, and modern remote after-loaders now reduce staff exposure while improving dose accuracy.
Indian physicians introduced radium-226 for cancer treatment during the early decades of the twentieth century. Records available with the erstwhile Directorate of Radiation Protection (DRP), Bhabha Atomic Research Centre (BARC), indicate that the first documented stock of radium arrived at the Radium Institute, Patna, in 1930, although some hospitals may have acquired radium earlier. Over the following decades, more than sixty-five Indian hospitals obtained radium sources for brachytherapy, collectively possessing about 20 grams of radium. Thousands of patients benefited from radium therapy at a time when alternative treatment methods were limited.
This article recalls the use of radium in India, the radiation-safety challenges encountered, and the coordinated national programme in which radium was withdrawn and replaced by safer alternatives.
Radium Use and Radiation Safety Challenges
Radium was the first radioactive material used extensively in cancer therapy. Its success transformed management of cancers such as carcinoma of the cervix and other malignancies amenable to brachytherapy. Yet the very properties that made radium therapeutically useful also created formidable safety concerns.
Radium-226 has a half-life of approximately 1,600 years. It is highly radiotoxic and, if incorporated into the body, behaves similarly to calcium and accumulates in bone. Even small amounts may remain in the body for prolonged periods, delivering substantial radiation doses. In addition, radium decays to radon gas and a series of radioactive daughter products. Inhalation of radon progeny can result in significant lung doses and increase in the risk of lung cancer.
Unlike modern sealed sources, many radium sources were manufactured decades ago. Long periods of use, sterilization, mechanical stress, and corrosion often led to deterioration of encapsulation, increasing the possibility of leakage and contamination.
Recognizing these hazards, the Directorate of Radiation Protection of BARC provided extensive assistance to hospitals throughout the country. DRP personnel inspected radium sources, carried out leak testing, investigated contamination incidents, recovered lost sources, and advised hospitals on radiation safety practices. These free services and played a major role in maintaining acceptable standards of radiation safety at a time when many institutions lacked trained personnel and suitable monitoring........
